Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Kidney Transplantation | Research article

Post renal transplant anemia: severity, causes and their association with graft and patient survival

Authors: Amir Schechter, Anat Gafter-Gvili, Daniel Shepshelovich, Ruth Rahamimov, Uzi Gafter, Eytan Mor, Avry Chagnac, Benaya Rozen-Zvi

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Post transplantation anemia (PTA) is common among kidney transplant patients. PTA is associated with increased graft loss and in most studies with increased mortality. However, the effect of the severity of anemia on this associations was not thoroughly evaluated.

Methods

Patients who underwent kidney transplantation in Rabin Medical Center (RMC) were included in the study. Data were collected during the years 2002–2016. Anemia was defined as hemoglobin (Hb) level less than 12 g/dL in women and less than 13 g/dL in men, in accordance with World Health Organization (WHO) criteria. Severe anemia was defined as hemoglobin lower than 11 g/dL. Primary outcome was a composite of patient and graft survival. We used univariate and multivariate models to evaluate association between severity and specific causes of anemia with the outcomes. As the risk associated with anemia changed over time we analyzed the risk separately for the early and the late period (before and after 1251 days).

Results

Our cohort included 1139 patients, 412 (36.2%) of which had PTA and 134 (11.7%) had severe anemia. On multivariable analysis, severe anemia was highly associated with the primary outcome at the early period (HR 6.26, 95% CI 3.74–10.5, p < 0.001). Anemia due to either AKI & acute rejection (11.9% of patients) or infection (16.7%), were associated with primary outcome at the early period (HR 9.32, 95% CI 5.3–26.41, p < 0.001 and HR 3.99, 95% CI 2.01–7.95, p < 0.001, respectively). There was non-significant trend for association between anemia due to Nutritional deficiencies (29.1%) and this outcome (HR 3.07, 95% CI 0.93–10.17, p = 0.067).

Conclusion

PTA is associated with graft loss and mortality especially during the first three years. Anemia severity affects this association. An anemia workup is recommended for PTA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shibagaki Y, Shetty A. Anemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant. 2004;19(9):2368–73.PubMedCrossRef Shibagaki Y, Shetty A. Anemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant. 2004;19(9):2368–73.PubMedCrossRef
2.
go back to reference Turkowski-Duhem A, Kamar N, Cointault O, et al. Predictive factors of anemia within the first year post renal transplant. Transplantation. 2005;80(7):903–9.PubMedCrossRef Turkowski-Duhem A, Kamar N, Cointault O, et al. Predictive factors of anemia within the first year post renal transplant. Transplantation. 2005;80(7):903–9.PubMedCrossRef
3.
go back to reference Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003;3(7):835–45.PubMedCrossRef Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003;3(7):835–45.PubMedCrossRef
4.
go back to reference Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006;21(12):3559–66.PubMedCrossRef Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006;21(12):3559–66.PubMedCrossRef
5.
go back to reference Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis. 2002;40(6):1306–18.PubMedCrossRef Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis. 2002;40(6):1306–18.PubMedCrossRef
6.
go back to reference Gafter-Gvili A, Ayalon-Dangur I, Cooper L, et al. Posttransplantation anemia in kidney transplant recipients: a retrospective cohort study. Medicine. 2017;96(32):e7735.PubMedPubMedCentralCrossRef Gafter-Gvili A, Ayalon-Dangur I, Cooper L, et al. Posttransplantation anemia in kidney transplant recipients: a retrospective cohort study. Medicine. 2017;96(32):e7735.PubMedPubMedCentralCrossRef
7.
go back to reference Hricik DE. Anemia after kidney transplantation--is the incidence increasing? Am J Transplant. 2003;3(7):771–2.PubMedCrossRef Hricik DE. Anemia after kidney transplantation--is the incidence increasing? Am J Transplant. 2003;3(7):771–2.PubMedCrossRef
8.
go back to reference Beshara S, Birgegard G, Goch J, Wahlberg J, Wikstrom B, Danielson BG. Assessment of erythropoiesis following renal transplantation. Eur J Haematol. 1997;58(3):167–73.PubMedCrossRef Beshara S, Birgegard G, Goch J, Wahlberg J, Wikstrom B, Danielson BG. Assessment of erythropoiesis following renal transplantation. Eur J Haematol. 1997;58(3):167–73.PubMedCrossRef
9.
go back to reference Teruel JL, Lamas S, Vila T, et al. Serum ferritin levels after renal transplantation: a prospective study. Nephron. 1989;51(4):462–5.PubMedCrossRef Teruel JL, Lamas S, Vila T, et al. Serum ferritin levels after renal transplantation: a prospective study. Nephron. 1989;51(4):462–5.PubMedCrossRef
10.
go back to reference Kahng K, Kang C, Kwak J. Changes in hemoglobin levels after renal transplantation. Transplant Proc. 1998;30(7):3023–4.PubMedCrossRef Kahng K, Kang C, Kwak J. Changes in hemoglobin levels after renal transplantation. Transplant Proc. 1998;30(7):3023–4.PubMedCrossRef
11.
go back to reference Miles AM, Markell MS, Daskalakis P, et al. Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transpl. 1997;11(4):313–5. Miles AM, Markell MS, Daskalakis P, et al. Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transpl. 1997;11(4):313–5.
12.
go back to reference Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DB. Serum erythropoietin levels after renal transplantation. N Engl J Med. 1989;321(3):151–7.PubMedCrossRef Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DB. Serum erythropoietin levels after renal transplantation. N Engl J Med. 1989;321(3):151–7.PubMedCrossRef
13.
go back to reference Choukroun G, Kamar N, Dussol B, et al. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol. 2012;23(2):360–8.PubMedPubMedCentralCrossRef Choukroun G, Kamar N, Dussol B, et al. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol. 2012;23(2):360–8.PubMedPubMedCentralCrossRef
14.
go back to reference Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N. Anemia following renal transplantation. Transplant Proc. 1998;30(7):3025–6.PubMedCrossRef Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N. Anemia following renal transplantation. Transplant Proc. 1998;30(7):3025–6.PubMedCrossRef
15.
go back to reference Heinze G, Kainz A, Horl WH, Oberbauer R. Mortality in renal transplant recipients given erythropoietins to increase hemoglobin concentration: cohort study. BMJ. 2009;339:b4018.PubMedPubMedCentralCrossRef Heinze G, Kainz A, Horl WH, Oberbauer R. Mortality in renal transplant recipients given erythropoietins to increase hemoglobin concentration: cohort study. BMJ. 2009;339:b4018.PubMedPubMedCentralCrossRef
16.
go back to reference Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17(3):889–99.PubMedCrossRef Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17(3):889–99.PubMedCrossRef
17.
go back to reference Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol. 2006;17(11):3240–7.PubMedCrossRef Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol. 2006;17(11):3240–7.PubMedCrossRef
18.
go back to reference Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study. Am J Transplant. 2007;7(4):818–24.PubMedCrossRef Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study. Am J Transplant. 2007;7(4):818–24.PubMedCrossRef
19.
go back to reference Huang Z, Song T, Fu L, et al. Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes. Int Urol Nephrol. 2015;47(9):1577–85.PubMedCrossRef Huang Z, Song T, Fu L, et al. Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes. Int Urol Nephrol. 2015;47(9):1577–85.PubMedCrossRef
20.
go back to reference de Andrade LG, Abrao JM, Carvalho MF. Anemia at one year is an independent risk factor of graft survival. Int Urol Nephrol. 2012;44(1):263–8.PubMedCrossRef de Andrade LG, Abrao JM, Carvalho MF. Anemia at one year is an independent risk factor of graft survival. Int Urol Nephrol. 2012;44(1):263–8.PubMedCrossRef
21.
go back to reference Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13(4):1084–90.PubMed Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13(4):1084–90.PubMed
22.
go back to reference Heidenreich S, Tepel M, Fahrenkamp A, Rahn KH. Prognostic value of serum erythropoietin levels in late acute rejection of renal transplants. Am J Kidney Dis. 1995;25(5):775–80.PubMedCrossRef Heidenreich S, Tepel M, Fahrenkamp A, Rahn KH. Prognostic value of serum erythropoietin levels in late acute rejection of renal transplants. Am J Kidney Dis. 1995;25(5):775–80.PubMedCrossRef
23.
go back to reference Eisenga MF, Minovic I, Berger SP, et al. Iron deficiency, anemia, and mortality in renal transplant recipients. Transpl Int. 2016;29(11):1176–83.PubMedCrossRef Eisenga MF, Minovic I, Berger SP, et al. Iron deficiency, anemia, and mortality in renal transplant recipients. Transpl Int. 2016;29(11):1176–83.PubMedCrossRef
24.
go back to reference Winkelmayer WC, Lorenz M, Kramar R, Horl WH, Sunder-Plassmann G. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant. 2004;4(12):2075–81.PubMedCrossRef Winkelmayer WC, Lorenz M, Kramar R, Horl WH, Sunder-Plassmann G. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant. 2004;4(12):2075–81.PubMedCrossRef
25.
go back to reference World Health Organization Technical report sereirs No 405, Nutritional Anemias: Report of a WHO Scientific Group Geneva, Switzerland1968. World Health Organization Technical report sereirs No 405, Nutritional Anemias: Report of a WHO Scientific Group Geneva, Switzerland1968.
26.
go back to reference Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Goldsmith D. Anemia after renal transplantation. Am J Kidney Dis. 2006;48(4):519–36.PubMedCrossRef Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Goldsmith D. Anemia after renal transplantation. Am J Kidney Dis. 2006;48(4):519–36.PubMedCrossRef
27.
go back to reference Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol. 2008;3(4):1168–74.PubMedPubMedCentralCrossRef Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol. 2008;3(4):1168–74.PubMedPubMedCentralCrossRef
28.
go back to reference Kidney Disease. Improving global outcomes (KDIGO) CKD work group, KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef Kidney Disease. Improving global outcomes (KDIGO) CKD work group, KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef
29.
go back to reference KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471–530.CrossRef KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471–530.CrossRef
31.
go back to reference Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603–11.PubMedCrossRef Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603–11.PubMedCrossRef
32.
go back to reference Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77(5):1241–7.PubMedCrossRef Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77(5):1241–7.PubMedCrossRef
33.
go back to reference de Benoist B. Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008;29(2 Suppl):S238–44.PubMedCrossRef de Benoist B. Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008;29(2 Suppl):S238–44.PubMedCrossRef
34.
go back to reference Gentil MA, Perez-Valdivia MA, Lopez-Mendoza M, et al. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES study. Transplant Proc. 2008;40(9):2922–4.PubMedCrossRef Gentil MA, Perez-Valdivia MA, Lopez-Mendoza M, et al. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES study. Transplant Proc. 2008;40(9):2922–4.PubMedCrossRef
35.
go back to reference Mirkazemi C, Peterson GM, Tenni PC, Jackson SL. Vitamin B12 deficiency in Australian residential aged care facilities. J Nutr Health Aging. 2012;16(3):277–80.PubMedCrossRef Mirkazemi C, Peterson GM, Tenni PC, Jackson SL. Vitamin B12 deficiency in Australian residential aged care facilities. J Nutr Health Aging. 2012;16(3):277–80.PubMedCrossRef
36.
go back to reference Kidney Disease. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;(2):1–138. Kidney Disease. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;(2):1–138.
37.
go back to reference Garrigue V, Szwarc I, Giral M, et al. Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort. Transplantation. 2014;97(2):168–75.PubMedCrossRef Garrigue V, Szwarc I, Giral M, et al. Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort. Transplantation. 2014;97(2):168–75.PubMedCrossRef
38.
go back to reference Ichimaru N, Obi Y, Nakazawa S, et al. Post-transplant Anemia has strong influences on renal and patient outcomes in living kidney transplant patients. Transplant Proc. 2016;48(3):878–83.PubMedCrossRef Ichimaru N, Obi Y, Nakazawa S, et al. Post-transplant Anemia has strong influences on renal and patient outcomes in living kidney transplant patients. Transplant Proc. 2016;48(3):878–83.PubMedCrossRef
39.
go back to reference Majernikova M, Rosenberger J, Prihodova L, et al. Posttransplant Anemia as a prognostic factor of mortality in kidney-transplant recipients. Biomed Res Int. 2017;2017:6987240.PubMedPubMedCentralCrossRef Majernikova M, Rosenberger J, Prihodova L, et al. Posttransplant Anemia as a prognostic factor of mortality in kidney-transplant recipients. Biomed Res Int. 2017;2017:6987240.PubMedPubMedCentralCrossRef
40.
go back to reference Freiberg M, Chiurchiu C, Capra R, et al. Associated factors and clinical implications of post transplant renal anemia. Medicina (B Aires). 2013;73(2):136–40. Freiberg M, Chiurchiu C, Capra R, et al. Associated factors and clinical implications of post transplant renal anemia. Medicina (B Aires). 2013;73(2):136–40.
41.
go back to reference Gheith O, Wafa E, Hassan N, et al. Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clin Exp Nephrol. 2009;13(4):361–6.PubMedCrossRef Gheith O, Wafa E, Hassan N, et al. Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clin Exp Nephrol. 2009;13(4):361–6.PubMedCrossRef
42.
go back to reference Kamar N, Rostaing L, Ignace S, Villar E. Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transpl. 2012;26(3):461–9.CrossRef Kamar N, Rostaing L, Ignace S, Villar E. Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transpl. 2012;26(3):461–9.CrossRef
43.
go back to reference Schjelderup P, Dahle DO, Holdaas H, et al. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study. Clin Transpl. 2013;27(6):E636–43.CrossRef Schjelderup P, Dahle DO, Holdaas H, et al. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study. Clin Transpl. 2013;27(6):E636–43.CrossRef
44.
go back to reference Shah N, Al-Khoury S, Afzali B, et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation. 2006;81(8):1112–8.PubMedCrossRef Shah N, Al-Khoury S, Afzali B, et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation. 2006;81(8):1112–8.PubMedCrossRef
45.
go back to reference Karakus S, Kanbay M, Koseoglu HK, Colak T, Haberal M. Causes of anemia in renal transplant recipients. Transplant Proc. 2004;36(1):164–5.PubMedCrossRef Karakus S, Kanbay M, Koseoglu HK, Colak T, Haberal M. Causes of anemia in renal transplant recipients. Transplant Proc. 2004;36(1):164–5.PubMedCrossRef
46.
go back to reference Mahmud SN, Aziz R, Ahmed E, et al. Anemia characteristics after renal transplantation. Transplant Proc. 2002;34(6):2428.PubMedCrossRef Mahmud SN, Aziz R, Ahmed E, et al. Anemia characteristics after renal transplantation. Transplant Proc. 2002;34(6):2428.PubMedCrossRef
47.
go back to reference Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.PubMedCrossRef Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.PubMedCrossRef
48.
go back to reference Augustine JJ, Knauss TC, Schulak JA, Bodziak KA, Siegel C, Hricik DE. Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant. 2004;4(12):2001–6.PubMedCrossRef Augustine JJ, Knauss TC, Schulak JA, Bodziak KA, Siegel C, Hricik DE. Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant. 2004;4(12):2001–6.PubMedCrossRef
49.
go back to reference Dobrolet NC, Webber SA, Blatt J, et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant. 2001;5(2):125–31.PubMedCrossRef Dobrolet NC, Webber SA, Blatt J, et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant. 2001;5(2):125–31.PubMedCrossRef
50.
go back to reference Suzuki S, Osaka Y, Nakai I, et al. Pure red cell aplasia induced by FK506. Transplantation. 1996;61(5):831–2.PubMedCrossRef Suzuki S, Osaka Y, Nakai I, et al. Pure red cell aplasia induced by FK506. Transplantation. 1996;61(5):831–2.PubMedCrossRef
51.
go back to reference Rozen-Zvi B, Gafter-Gvili A, Zingerman B, et al. Intravenous iron supplementation after kidney transplantation. Clin Transpl. 2012;26(4):608–14.CrossRef Rozen-Zvi B, Gafter-Gvili A, Zingerman B, et al. Intravenous iron supplementation after kidney transplantation. Clin Transpl. 2012;26(4):608–14.CrossRef
52.
go back to reference Mudge DW, Tan KS, Miles R, et al. A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation. Transplantation. 2012;93(8):822–6.PubMedCrossRef Mudge DW, Tan KS, Miles R, et al. A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation. Transplantation. 2012;93(8):822–6.PubMedCrossRef
Metadata
Title
Post renal transplant anemia: severity, causes and their association with graft and patient survival
Authors
Amir Schechter
Anat Gafter-Gvili
Daniel Shepshelovich
Ruth Rahamimov
Uzi Gafter
Eytan Mor
Avry Chagnac
Benaya Rozen-Zvi
Publication date
01-12-2019

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue